BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18803590)

  • 1. Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology.
    Bioulac-Sage P; Laumonier H; Rullier A; Cubel G; Laurent C; Zucman-Rossi J; Balabaud C
    Liver Int; 2009 Mar; 29(3):459-65. PubMed ID: 18803590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunostaining of glutamine synthetase is a sensitive and specific marker for diagnosing focal nodular hyperplasia in needle biopsy.
    Tsai JH; Jeng YM; Pan CC; Lu SW; Kuo YJ
    Pathology; 2012 Dec; 44(7):605-10. PubMed ID: 22990279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers.
    Bioulac-Sage P; Cubel G; Balabaud C; Zucman-Rossi J
    Semin Liver Dis; 2011 Feb; 31(1):91-103. PubMed ID: 21344354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules.
    Rebouissou S; Couchy G; Libbrecht L; Balabaud C; Imbeaud S; Auffray C; Roskams T; Bioulac-Sage P; Zucman-Rossi J
    J Hepatol; 2008 Jul; 49(1):61-71. PubMed ID: 18466996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice.
    van Aalten SM; Verheij J; Terkivatan T; Dwarkasing RS; de Man RA; Ijzermans JN
    J Hepatol; 2011 Jul; 55(1):120-5. PubMed ID: 21145863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma.
    Joseph NM; Ferrell LD; Jain D; Torbenson MS; Wu TT; Yeh MM; Kakar S
    Mod Pathol; 2014 Jan; 27(1):62-72. PubMed ID: 23807780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
    Shafizadeh N; Genrich G; Ferrell L; Kakar S
    Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic challenges of focal nodular hyperplasia: interobserver variability, accuracy, and the utility of glutamine synthetase immunohistochemistry.
    Rowan DJ; Allende DS; Bellizzi AM; Gill RM; Liu X; McKenzie CA; Moreira RK; Mounajjed T; Said S; Westerhoff M; Jenkins SM; Batts KP; Burgart LJ; Lamps LW; Graham RP
    Histopathology; 2021 Nov; 79(5):791-800. PubMed ID: 34080211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes.
    Bioulac-Sage P; Cubel G; Taouji S; Scoazec JY; Leteurtre E; Paradis V; Sturm N; Nhieu JT; Wendum D; Bancel B; Ramos J; Paraf F; Saint Paul MC; Michalak S; Fabre M; Guettier C; Le Bail B; Zucman-Rossi J; Balabaud C
    Am J Surg Pathol; 2012 Nov; 36(11):1691-9. PubMed ID: 23060349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic use of cytokeratins, CD34, and neuronal cell adhesion molecule staining in focal nodular hyperplasia and hepatic adenoma.
    Ahmad I; Iyer A; Marginean CE; Yeh MM; Ferrell L; Qin L; Bifulco CB; Jain D
    Hum Pathol; 2009 May; 40(5):726-34. PubMed ID: 19157505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of well-differentiated hepatocellular lesions: role of immunohistochemistry and other ancillary techniques.
    Shafizadeh N; Kakar S
    Adv Anat Pathol; 2011 Nov; 18(6):438-45. PubMed ID: 21993269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
    Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
    Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia.
    Paradis V; Bièche I; Dargère D; Laurendeau I; Nectoux J; Degott C; Belghiti J; Vidaud M; Bedossa P
    Gastroenterology; 2003 Mar; 124(3):651-9. PubMed ID: 12612904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique hypervascular nodules in alcoholic liver cirrhosis: identical to focal nodular hyperplasia-like nodules?
    Nakashima O; Kurogi M; Yamaguchi R; Miyaaki H; Fujimoto M; Yano H; Kumabe T; Hayabuchi N; Hisatomi J; Sata M; Kojiro M
    J Hepatol; 2004 Dec; 41(6):992-8. PubMed ID: 15582133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cell differentiation in hepatocellular adenomas: implications for histopathological diagnosis.
    Gouysse G; Frachon S; Hervieu V; Fiorentino M; d'Errico A; Dumortier J; Boillot O; Partensky C; Grigioni WF; Scoazec JY
    J Hepatol; 2004 Aug; 41(2):259-66. PubMed ID: 15288475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal nodular hyperplasia of the liver: pathological analysis of 11 cases.
    Pan Y; Wang ZM; Mou LJ; Teng XD; Zheng ZJ; Ying LX
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):199-203. PubMed ID: 15138109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal nodular hyperplasia-like nodules arising in the setting of hepatic vascular disorders with portosystemic shunting show β-catenin activation.
    Umetsu SE; Joseph NM; Cho SJ; Morotti R; Deshpande V; Jain D; Kakar S
    Hum Pathol; 2023 Dec; 142():20-26. PubMed ID: 37806391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A triple stain of reticulin, glypican-3, and glutamine synthetase: a useful aid in the diagnosis of liver lesions.
    Swanson BJ; Yearsley MM; Marsh W; Frankel WL
    Arch Pathol Lab Med; 2015 Apr; 139(4):537-42. PubMed ID: 25822763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple spontaneous liver cell adenomas of different types (liver adenomatosis).
    Bisceglia M; Gatta A; Tomezzoli A; Donataccio M
    Adv Anat Pathol; 2009 May; 16(3):172-9. PubMed ID: 19395881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic resection for inflammatory hepatocellular adenomas: pathological identification of micronodules expressing inflammatory proteins.
    Bioulac-Sage P; Laumonier H; Cubel G; Rossi JZ; Balabaud C
    Liver Int; 2010 Jan; 30(1):149-54. PubMed ID: 19845852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.